CTKB

Cytek Biosciences Stock Analysis

AI Rating

Fair
  • Quality4/10
  • Growth↓ 2/10
  • Value↓ 2/10
Cytek Biosciences sales and earnings growth
CTKB Growth
Fair
  • Revenue Y/Y↓ 0.52%
  • EPS Y/Y↓ -940.00%
  • FCF Y/Y↓ -139.31%
Cytek Biosciences gross and profit margin trends
CTKB Profitability
Fair
  • Gross margin ↑ 51.80%
  • EPS margin↓ -33.00%
  • ROIC 5Y↓ -4.94%
Cytek Biosciences net debt vs free cash flow
CTKB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -64.0

Cytek Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗